Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 5.Ident. | Authors (with country if any) | Title |
---|---|---|
002A31 | A. Novikov ; E. N. Alexandrova ; A. N. Gerasimov [Russie] ; A. S. Avdeeva ; G. V. Lukina ; Y. A. Sigidin ; T. V. Popkova ; E. Y. Panasyuk ; E. L. Nasonov | THU0122 Multi-Biomarker Scores as Predictors of Response to Biologic Therapies in Rheumatoid Arthritis |
003149 | A. S. Avdeeva ; E. N. Alexandrova ; E. Y. Panasyuk ; G. V. Lukina ; E. L. Nasonov [Russie] | AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA) |
003225 | E. V. Udachkina [Russie] ; D. S. Novikova [Russie] ; T. V. Popkova [Russie] ; A. S. Avdeeva [Russie] ; A. A. Novikov [Russie] ; E. N. Alexandrova [Russie] ; A. V. Volkov [Russie] ; E. L. Nasonov [Russie] | AB0306 Tocilizumab therapy resulted in significantly increased heart rate variability and improved lipid profile in patients with rheumatoid arthritis |
003234 | A. S. Avdeeva [Russie] ; E. N. Alexandrova [Russie] ; A. V. Smirnov [Russie] ; A. A. Novikov [Russie] ; M. V. Cherkasova [Russie] ; E. Y. Panasyuk [Russie] ; E. L. Nasonov [Russie] | AB0299 Association of basal level antibodies to modified citrullinated vimentin (anti-mcv) with joint destruction in rheumatoid arthritis (ra) patients during the tocilizumab (tcz) therapy |
003263 | A. S. Avdeeva ; E. N. Alexandrova ; A. A. Novikov ; E. Y. Panasyuk ; M. V. Cherkasova ; E. L. Nasonov [Russie] | AB0259 The high basal level antibodies to modified citrullinated vimentin (anti-MCV) – predictive factor of response to tocilizumab therapy in rheumatoid arthritis |
This area was generated with Dilib version V0.6.34. |